AI is being employed to standardize TIL scoring in melanoma, enhancing pathology workflows and reducing scoring variability. This collaboration between AI and clinicians aims to expedite assessments and improve accuracy for better patient outcomes, particularly in oncology diagnostics.

Read More:

• 🔗 www.cancernetwork.com